Avid Bioservices Inc (CDMO)

[investingdog]

<<We need 13.3 months mos minimum on frontline trial that's 4 weeks longer then the Avastin results>>

Well, this is from your link on Avastin trial. Is MOS 16.5?? What' wrong here?

"To date, 27 patients (68%) have had documented disease progression and 23 patients (58%) have died. Five patients (13%) are still on active treatment. The median progression-free survival was 7.9 months (95% CI, 6.0-11.1) (Fig. 1), indicating a statistically significant improvement over the historical control (evidenced by the lower boundary of the confidence interval above the historical median progression-free survival mark of 4.5 months). Median overall survival was 16.5 months (95% CI, 13.6-31.2) (Fig. 1)."